A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung cancer ...

New research on Hologic's AI-driven breast cancer detection technologies, including a study focused on invasive lobular cancer, was presented at the Society of Breast Imaging (SBI) Symposium over the ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response ...

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to study results.Patients determined by a biology-guided AI model to be at high ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

A new lung detection machine at CHRISTUS St. Frances Cabrini Hospital is helping doctors identify lung issues earlier.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...

Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts, including two oral presentations, featuring data generated using its ...

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...